Proteolytic fragmentation and sugar chains of plasma ADAMTS13 purified by a conformation-dependent monoclonal antibody

Journal of Biochemistry

Volumn 148, Issue 4, 2010, Pages 403-411

  Hiura, Hisahide ^a   Matsui, Taei ^b   Matsumoto, Masanori ^a   Hori, Yuji ^a   Isonishi, Ayami ^a   Kato, Seiji ^a   Iwamoto, Takaaki ^a   Mori, Toshio ^a   Fujimura, Yoshihiro ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

enzyme digestion; lectin blotting; plasma ADAMTS13; purification

Indexed keywords

AMINO ACID; ASIALOGLYCOPROTEIN; CARBOHYDRATE; ENZYME; LECTIN; LEUKOCYTE ELASTASE; MONOCLONAL ANTIBODY; PLASMIN; PROTEINASE; SIALIC ACID; SUGAR; THROMBIN; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ARTICLE; HUMAN; PLASMA; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN PURIFICATION;

ABO BLOOD-GROUP SYSTEM; ADAM PROTEINS; ANTIBODIES, MONOCLONAL; ENZYME STABILITY; EPITOPES; HUMANS; HYDROGEN-ION CONCENTRATION; IONS; METALS; MODELS, MOLECULAR; PEPTIDE HYDROLASES; PROTEIN CONFORMATION;

EID: 77958041119     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvq075     Document Type: Article

References (34)

1. Furlan, M., Robles, R., and Lämmle, B. (1996) Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 87, 4223-4234
2. Tsai, H.-M. (1996) Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 87, 4235-4244
3. Levy, G.G., Nichols, W.C., Lian, E.C., Foroud, T., McClintick, J.N., McGee, B.M., Yang, A.Y., Siemieniak, D.R., Stark, K.R., Gruppo, R., Sarode, R., Shurin, S.B., Chandrasekaran, V., Stabler, K.R., Sabio, H., Bouhassira, E.E., Upshaw, J.D. Jr, Ginburg, D., and Tsai, H.M. (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413, 488-494 (Pubitemid 32938741)
4. Dong, J.F., Moake, J.L., Nolasco, L., Bernardo, A., Arceneaux, W., Shrimpton, C.N., Schade, A.J., McIntire, L.V., Fujikawa, K., and Ló pez, J.A. (2002) ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 100, 4033-4039
5. Ruggeri, Z.M. (1997) von Willebrand Factor. J. Clin. Invest. 99, 559-564
6. Sadler, J.E. (1998) Biochemistry and genetics of Willebrand factor. Annu. Rev. Biochem. 67, 395-424
7. Furlan, M., Robles, R., Galbusera, M., Remuzzi, G., Kyrle, P.A., Brenner, B., Krause, M., Scharrer, I., Aumann, V., Mittler, U., Solenthaler, M., and Lämmle, B. (1998) von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N. Engl. J. Med. 339, 1578-1584 (Pubitemid 28536132)
8. Tsai, H.M. and Lian, E.C.Y. (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N. Engl. J. Med. 339, 1585-1594
9. Moake, J.L. (2002) Thrombotic microangiopathies. N. Engl. J. Med. 347, 589-600
10. George, J.N. (2006) Clinical practice. Thrombotic thrombocytopenic purpura. N. Engl. J. Med. 354, 1927-1935
11. Fujimura, Y. and Matsumoto, M. (2010) Registry of 919 patients with thrombotic microangiopathies across Japan: Database of Nara Medical University during 1998-2008. Inter. Med. 49, 7-15
12. Park, Y.D., Yoshioka, A., Kawa, K., Ishizashi, H., Yagi, H., Yamamoto, Y., Matsumoto, M., and Fujimura, Y. (2002) Impaired activity of plasma von Willebrand factor-cleaving protease may predict the occurrence of hepatic veno-occlusive disease after stem cell transplantation. Bone Marrow Transplant 29, 789-794
13. Ko, S., Okano, E., Kanehiro, H., Matsumoto, M., Ishizashi, H., Uemura, M., Fujimura, Y., Tanaka, K., and Nakajima, Y. (2006) Plasma ADAMTS13 activity may predict early adverse events in living donor liver transplantation: Observations in 3 cases. Liver Transpl. 12, 859-869
14. Uemura, M., Fujimura, Y., Matsumoto, M., Ishizashi, H., Kato, S., Matsuyama, T., Isonishi, A., Ishikawa, M., Yagita, M., Morioka, C., Yoshiji, H., Tsujimoto, T., Kurumatani, N., and Fukui, H. (2008) Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis. Thromb. Haemost. 99, 1019-1029
15. Ono, T., Mimuro, J., Madoiwa, S., Soejima, K., Kashiwakura, Y., Ishiwata, A., Takano, K., Ohmori, T., and Sakata, Y. (2006) Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure. Blood 107, 528-534
16. Morioka, C., Uemura, M., Matsuyama, T., Matsumoto, M., Kato, S., Ishikawa, M., Ishizashi, H., Fujimoto, M., Sawai, M., Yoshida, M., Mitoro, A., Yamao, J., Tsujimoto, T., Yoshiji, H., Urizono, Y., Hata, M., Nishino, K., Okuchi, K., Fujimura, Y., and Fukui, H. (2008) Plasma ADAMTS13 activity parallels the APACHE II score, reflecting an early prognostic indicator for patients with severe acute pancreatitis. Scand. J. Gatroentero. 43, 1387-1396
17. Crawley, J.T., Lam, J.K., Rance, J.B., Mollica, L.R., O'Donnell, J.S., and Lane, D.A. (2005) Proteolytic inactivation of ADAMTS13 by thrombin and plasmin. Blood 105, 1085-1093
18. Lam, J.K., Chion, C.K., Zanardelli, S., Lane, D.A., and Crawley, J.T. (2007) Further characterization of ADAMTS-13 inactivation by thrombin. J. Thromb. Haemost. 5, 1010-1018
19. Gerritsen, H.E., Robles, R., Lämmle, B., and Furlan, M. (2001) Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood 98, 1654-1661
20. Fujikawa, K., Suzuki, H., McMullen, B., and Chung, D. (2001) Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 98, 1662-1666
21. Uemura, M., Tatsumi, K., Matsumoto, M., Fujimoto, M., Matsuyama, T., Ishikawa, M., Iwamoto, T.A., Mori, T., Wanaka, A., Fukui, H., and Fujimura, Y. (2005) Localization of ADAMTS13 to the stellate cells of human liver. Blood 106, 922-924
22. Nakagawa, T., Moriki, T., Yamaguchi, Y., Igari, A., Soejima, K., Matsumoto, M., Fujimura, Y., and Murata, M. (2009) Multiple mapping of peptide sequences recognized by various monoclonal anti-ADAMTS13 antibodies with functional or nonfunctional effects on the catalytic activity. Blood 114, 1233 (Abs 3184)
23. Soejima, K., Nakamura, H., Hirashima, M., Morikawa, W., Nozaki, C., and Nakagaki, T. (2006) Analysis on the molecular species and concentration of circulating ADAMTS13 in Blood. J. Biochem. 139, 147-154
24. Kato, S., Matsumoto, M., Matsuyama, T., Isonishi, A., Hiura, H., and Fujimura, Y. (2006) Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity. Transfusion 46, 1444-1452
25. Matsudaira, P. (1987) Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J. Biol. Chem. 262, 10035-10038
26. Anderson, P.J., Kokame, K., and Sadler, J.E. (2006) Zinc and calciumions cooperatively modulate ADAMTS13 activity. J. Biol. Chem. 281, 850-857
27. Gardner, M.D., Chion, C.K., de Groot, R., Shah, A., Crawley, J.T., and Lane, D.A. (2009) A functional calcium-binding site in the metalloprotease domain of ADAMTS13. Blood 113, 1149-1157
28. Akiyama, M., Takeda, S., Kokame, K., Takagi, J., and Miyata, T. (2009) Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor. Proc. Natl Acad. Sci. USA 106, 19274-19279
29. Ricketts, L.M., Dlugosz, M., Luther, K.B., Haltiwanger, R.S., and Majerus, E.M. (2007) O-fucosylation is required for ADAMTS13 secretion. J. Biol. Chem. 282, 17014-17023
30. Zhou, W. and Tsai, H.-M. (2009) N-Glycans of ADAMTS13 modulate its secretion and von Willebrand factor cleaving activity. Blood 113, 929-935
31. Breitfeld, P.P., Simmons, C.F., Strous, G.J., Geuze, H.J., and Schwartz, A.L. (1985) Cell biology of the asialoglycoprotein receptor system: a model of receptor-mediated endocytosis. Inter. Eev. Cytol. 97, 47-95
32. Steirer, L.M., Park, E.I., Townsend, R.R., and Baenziger, J.U. (2009) The asialoglycoprotein receptor regulates levels of plasma glycoproteins terminating with sialic acid alpha2,6-galactose. J. Biol. Chem. 284, 3777-3783
33. Bowen, D.J. (2003) An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13. J. Thromb. Haemost. 1, 33-40
34. Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M., Meng, E.C., and Ferrin, T.E. (2004) UCSF Chimera-A visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612